BIOL - צמיחת הכנסות ב-12 חודשים נגררים Biolase Inc.

BIOLASE, Inc. (BIOL) leads the dental laser segment, attracting clinics by facilitating the transition from drills to high-tech surgery. Financial stability relies on the regular sale of consumables alongside cyclical system procurement. The LTM annual change in sales volume reflects the dynamics of these processes, where 6.10 represents the current metric level. Stability is maintained through the modernization of assembly lines and strict control over emitter calibration.
biolase.com (BIOL) - פילוחי מדדים ודוחות פיננסיים

For BIOLASE, Inc. (BIOL), a dental equipment manufacturer, the relative sales growth over a 12-month period compared to the previous year reflects the pace of overcoming medical conservatism and the dependence on insurance payouts. This metric calculates the percentage change in TTM total revenue, allowing investors to assess the sustainability of business expansion amid operating losses and component shortage risks to avoid acquiring the asset at its peak valuation.